Financhill
Sell
26

CNC Quote, Financials, Valuation and Earnings

Last price:
$39.88
Seasonality move :
4.58%
Day range:
$39.39 - $40.11
52-week range:
$25.08 - $66.81
Dividend yield:
0%
P/E ratio:
8.66x
P/S ratio:
0.11x
P/B ratio:
0.94x
Volume:
2.5M
Avg. volume:
7.1M
1-year change:
-34.42%
Market cap:
$19.6B
Revenue:
$163.1B
EPS (TTM):
-$10.82

Analysts' Opinion

  • Consensus Rating
    Centene Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 14 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $40.41, Centene Corp. has an estimated upside of 1.31% from its current price of $39.89.
  • Price Target Downside
    According to analysts, the lowest downside price target is $32.00 representing 100% downside risk from its current price of $39.89.

Fair Value

  • According to the consensus of 18 analysts, Centene Corp. has 1.31% upside to fair value with a price target of $40.41 per share.

CNC vs. S&P 500

  • Over the past 5 trading days, Centene Corp. has overperformed the S&P 500 by 1.18% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Centene Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Centene Corp. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Centene Corp. reported revenues of $49.7B.

Earnings Growth

  • Centene Corp. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Centene Corp. reported earnings per share of -$13.50.
Enterprise value:
37.3B
EV / Invested capital:
0.97x
Price / LTM sales:
0.11x
EV / EBIT:
12.65x
EV / Revenue:
0.20x
PEG ratio (5yr expected):
0.13x
EV / Free cash flow:
11.11x
Price / Operating cash flow:
5.90x
Enterprise value / EBITDA:
2.82x
Gross Profit (TTM):
--
Return On Assets:
-6.28%
Net Income Margin (TTM):
-2.85%
Return On Equity:
-20.3%
Return On Invested Capital:
-11.98%
Operating Margin:
-0.41%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $150.1B $161.7B $185.9B $42B $49.7B
Gross Profit -- -- -- -- --
Operating Income $4B $3B $1.1B $673M -$202M
EBITDA $5.7B $5.9B -- $1.4B --
Diluted EPS $4.45 $5.77 -$10.82 $1.36 -$13.50
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $28.1B $33.3B $41.4B $37.4B $44.1B
Total Assets $77.7B $81.2B $84.4B $82.4B $82.1B
Current Liabilities $25B $31.3B $36.9B $34.1B $40.6B
Total Liabilities $51.1B $55.6B $59B $54.9B $61B
Total Equity $26.7B $25.6B $25.4B $27.4B $21.1B
Total Debt $22.7B $21.6B $19.1B $17.6B $17.6B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $6.3B $958M $4.1B -$978M $1.4B
Cash From Investing -$108M -$2.1B -$105M -$839M $1.2B
Cash From Financing -$3.1B -$2.6B -$1.4B -$1.2B $9M
Free Cash Flow $5.5B $245M $3.4B -$1.1B $1.1B
CNC
Sector
Market Cap
$19.6B
$28.1M
Price % of 52-Week High
59.71%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
7.91%
-1.49%
1-Year Price Total Return
-34.42%
-17.13%
Beta (5-Year)
0.476
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $39.50
200-day SMA
Sell
Level $43.16
Bollinger Bands (100)
Buy
Level 30.12 - 38.56
Chaikin Money Flow
Buy
Level 256.3M
20-day SMA
Buy
Level $39.17
Relative Strength Index (RSI14)
Buy
Level 57.66
ADX Line
Buy
Level 9.4
Williams %R
Neutral
Level -41.2027
50-day SMA
Buy
Level $37.20
MACD (12, 26)
Buy
Level 0.71
25-day Aroon Oscillator
Buy
Level 60
On Balance Volume
Neutral
Level 306.1M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.7456)
Sell
CA Score (Annual)
Level (-0.3623)
Sell
Beneish M-Score (Annual)
Level (-2.0011)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.3944)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Stock Forecast FAQ

In the current month, CNC has received 3 Buy ratings 14 Hold ratings, and 1 Sell ratings. The CNC average analyst price target in the past 3 months is $40.41.

  • Where Will Centene Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Centene Corp. share price will rise to $40.41 per share over the next 12 months.

  • What Do Analysts Say About Centene Corp.?

    Analysts are divided on their view about Centene Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Centene Corp. is a Sell and believe this share price will drop from its current level to $32.00.

  • What Is Centene Corp.'s Price Target?

    The price target for Centene Corp. over the next 1-year time period is forecast to be $40.41 according to 18 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 14 analysts rate the stock a Hold.

  • Is CNC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Centene Corp. is a Hold. 14 of 18 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CNC?

    You can purchase shares of Centene Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Centene Corp. shares.

  • What Is The Centene Corp. Share Price Today?

    Centene Corp. was last trading at $39.88 per share. This represents the most recent stock quote for Centene Corp.. Yesterday, Centene Corp. closed at $39.89 per share.

  • How To Buy Centene Corp. Stock Online?

    In order to purchase Centene Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock